Loading company…
VintaBio provides cell and gene therapy manufacturing services to research and healthcare organizations.
Founded in 2020, VintaBio is based in Pennsylvania and provides manufacturing services to pharmaceutical, biotechnology, academic, and government organizations developing therapies for clinical use. Its services include research, cGMP-grade vector services, plasmid manufacturing, analytical method development, and regulatory support. In April 2023, it raised USD 64 million in venture funding led by Decheng Capital. The funding was intended to support a 22,500-square-foot manufacturing facility in Philadelphia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in